|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
Study to determine the safety, tolerability, and anti-tumor effectiveness of an oral investigational drug, suberoylanilide hydroxamic acid (Vorinostat, MK-0683), in the treatment of advanced malignant pleural mesothelioma.
|
|
|
Disease Condition |
Pleural Mesothelioma
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Oncology
|
|
|
Start date of Trial |
7/1/2005
|
Closing Date of Trial |
10/1/2010
|
|
|
|